🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/1992 | 23,86 | 24,51 | 23,62 | 24,51 | +1,99% | 3,75% | 4.443.939 |
| 29/05/1992 | 24,33 | 24,45 | 23,91 | 24,03 | -1,23% | 2,21% | 3.939.222 |
| 28/05/1992 | 23,44 | 24,33 | 23,38 | 24,33 | +3,03% | 4,07% | 3.624.613 |
| 27/05/1992 | 23,62 | 23,74 | 23,44 | 23,62 | -0,25% | 1,26% | 3.590.238 |
| 26/05/1992 | 24,27 | 24,27 | 23,50 | 23,68 | -2,46% | 3,19% | 4.962.699 |
| 22/05/1992 | 23,68 | 24,33 | 23,68 | 24,27 | +3,12% | 2,77% | 7.012.378 |
| 21/05/1992 | 23,38 | 23,60 | 23,38 | 23,54 | -0,25% | 0,94% | 4.597.157 |
| 20/05/1992 | 23,72 | 23,78 | 23,58 | 23,60 | -0,42% | 0,84% | 4.360.099 |
| 19/05/1992 | 23,22 | 23,82 | 23,18 | 23,70 | +2,32% | 2,74% | 5.937.130 |
| 18/05/1992 | 23,10 | 23,28 | 23,08 | 23,16 | +0,52% | 0,86% | 3.924.970 |
| 15/05/1992 | 23,06 | 23,18 | 23,02 | 23,04 | -0,69% | 0,69% | 6.623.779 |
| 14/05/1992 | 23,40 | 23,42 | 23,06 | 23,20 | -1,35% | 1,53% | 4.756.243 |
| 13/05/1992 | 23,56 | 23,60 | 23,40 | 23,52 | -0,08% | 0,84% | 3.030.816 |
| 12/05/1992 | 23,78 | 23,82 | 23,46 | 23,54 | -0,75% | 1,50% | 5.017.195 |
| 11/05/1992 | 23,62 | 23,72 | 23,58 | 23,72 | +0,59% | 0,59% | 2.713.272 |
| 08/05/1992 | 23,58 | 23,62 | 23,42 | 23,58 | +0,17% | 0,84% | 3.150.288 |
| 07/05/1992 | 23,32 | 23,56 | 23,32 | 23,54 | +0,94% | 1,02% | 3.477.264 |
| 06/05/1992 | 23,56 | 23,66 | 23,32 | 23,32 | -0,76% | 1,43% | 4.600.930 |
| 05/05/1992 | 23,50 | 23,54 | 23,42 | 23,50 | +0,17% | 0,51% | 4.690.219 |
| 04/05/1992 | 23,06 | 23,52 | 23,04 | 23,46 | +2,52% | 2,07% | 5.548.531 |
| 01/05/1992 | 22,94 | 22,96 | 22,60 | 22,88 | -0,78% | 1,56% | 5.633.419 |
| 30/04/1992 | 22,88 | 23,06 | 22,78 | 23,06 | +0,87% | 1,22% | 6.096.216 |
| 29/04/1992 | 22,56 | 22,86 | 22,54 | 22,86 | +1,86% | 1,41% | 6.486.701 |
| 28/04/1992 | 22,48 | 22,58 | 22,15 | 22,44 | -0,09% | 1,94% | 6.117.595 |
| 27/04/1992 | 22,19 | 22,56 | 22,09 | 22,46 | +0,53% | 2,15% | 5.745.974 |
| 24/04/1992 | 22,42 | 22,58 | 22,28 | 22,34 | +0,54% | 1,33% | 6.242.726 |
| 23/04/1992 | 22,64 | 22,70 | 21,71 | 22,22 | -2,02% | 4,39% | 14.971.099 |
| 22/04/1992 | 23,10 | 23,14 | 22,60 | 22,68 | -1,64% | 2,32% | 5.673.662 |
| 21/04/1992 | 23,00 | 23,14 | 22,76 | 23,06 | +0,43% | 1,64% | 6.236.438 |
| 20/04/1992 | 23,26 | 23,38 | 22,92 | 22,96 | -3,02% | 1,97% | 7.280.875 |